Cargando…

AMPed up to treat prostate cancer: novel AMPK activators emerge for cancer therapy

Despite recent advances in the treatment for metastatic prostatic adenocarcinoma, clinical management of this tumor type remains a major challenge, and there is as of yet no durable cure for advanced disease. Developing pathways that could be co-targeted alongside the androgen receptor or that would...

Descripción completa

Detalles Bibliográficos
Autores principales: Schiewer, Matthew J, Knudsen, Karen E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3992071/
https://www.ncbi.nlm.nih.gov/pubmed/24562461
http://dx.doi.org/10.1002/emmm.201303737

Ejemplares similares